{"id":"nasal-sprays","safety":{"commonSideEffects":[{"rate":null,"effect":"Nasal irritation"},{"rate":null,"effect":"Epistaxis"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Taste disturbance"}]},"_chembl":{"chemblId":"CHEMBL14012","moleculeType":"Small molecule","molecularWeight":"218.30"},"_dailymed":{"setId":"0870e5ec-8d97-6f04-e063-6294a90ab30a","title":"CLEANOTE SALINE NASAL SPRAYS (SODIUM CHLORIDE 0.9%) AEROSOL, SPRAY [CLOUDGOOSE BIOLOGY SCIENCE & TECHNOLOGY CO., LTD.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Nasal sprays are a delivery formulation rather than a specific drug entity. They work by depositing medication onto the nasal epithelium, which has high vascularity and permeability, allowing for rapid absorption into systemic circulation or local therapeutic effect in the nasal cavity and upper respiratory tract. The specific mechanism depends entirely on the active pharmaceutical ingredient contained within the spray formulation.","oneSentence":"Nasal sprays deliver pharmaceutical agents directly to the nasal mucosa for local or systemic absorption.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T05:17:18.018Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07498374","phase":"NA","title":"Efficacy and Safety of Fully Resorbable Sinus Drug-eluting Stents in Patients With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps After Surgery: A Prospective, Randomized Controlled Trial","status":"RECRUITING","sponsor":"Tang-Du Hospital","startDate":"2026-01-21","conditions":"Eosinophilic Chronic Rhinosinusitis With Nasal Polyps","enrollment":192},{"nctId":"NCT05921448","phase":"EARLY_PHASE1","title":"Vaccine Pandemic Preparedness Through Airway Immunology Characterization","status":"ACTIVE_NOT_RECRUITING","sponsor":"Copenhagen Respiratory Research","startDate":"2025-05-19","conditions":"Influenza, Human","enrollment":60},{"nctId":"NCT07492966","phase":"","title":"Exosomes Effect on Visual Function in CVI","status":"COMPLETED","sponsor":"Hatice Semrin Timlioglu İper","startDate":"2024-06-30","conditions":"Cortical Visual Impairment, Visual Function","enrollment":32},{"nctId":"NCT06338995","phase":"PHASE3","title":"A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2024-04-29","conditions":"Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)","enrollment":510},{"nctId":"NCT06850805","phase":"PHASE3","title":"Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps","status":"RECRUITING","sponsor":"Optinose US Inc.","startDate":"2025-07-28","conditions":"Chronic Rhinosinusitis Without Nasal Polyps","enrollment":84},{"nctId":"NCT07226362","phase":"PHASE1","title":"A Study Evaluating the Safety, Tolerability and Pharmacokinetics of ASY202 in Healthy Adults","status":"COMPLETED","sponsor":"Aspeya Switzerland SA","startDate":"2025-06-09","conditions":"Safety, and Tolerability","enrollment":44},{"nctId":"NCT03794076","phase":"PHASE1, PHASE2","title":"Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia","status":"RECRUITING","sponsor":"Vishwajit Nimgaonkar, MD PhD","startDate":"2019-04-01","conditions":"Schizophrenia, Schizo Affective Disorder","enrollment":160},{"nctId":"NCT07100496","phase":"PHASE4","title":"Evaluation of MIG-SPRAY Treatment on Migraine","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2025-09-15","conditions":"Migraine","enrollment":45},{"nctId":"NCT07466173","phase":"NA","title":"The Importance of Insulin Action in the Brain for the Immune System During Physical Activity-Overweight","status":"NOT_YET_RECRUITING","sponsor":"University of Ulm","startDate":"2026-04","conditions":"Insulin Sensitivity","enrollment":8},{"nctId":"NCT07475546","phase":"PHASE3","title":"Combination Gerotherapeutic Interventions for Healthspan Improvement","status":"ACTIVE_NOT_RECRUITING","sponsor":"AgelessRx","startDate":"2025-07-23","conditions":"Healthspan Improvement, Aging, Longevity","enrollment":30},{"nctId":"NCT05709977","phase":"NA","title":"Acupuncture for Nasal Congestion in Allergic Rhinitis","status":"COMPLETED","sponsor":"Johanna Maria Vermeulen","startDate":"2023-04-20","conditions":"Allergic Rhinitis","enrollment":11},{"nctId":"NCT07053345","phase":"PHASE4","title":"A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant Depression","status":"RECRUITING","sponsor":"Janssen Korea, Ltd., Korea","startDate":"2025-06-09","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":47},{"nctId":"NCT07465965","phase":"PHASE1","title":"A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults","status":"RECRUITING","sponsor":"Shanghai World Leader Pharmaceutical Co., Ltd.","startDate":"2026-03-02","conditions":"Overweight, Obesity","enrollment":60},{"nctId":"NCT05275686","phase":"PHASE2","title":"Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)","status":"RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2022-04-20","conditions":"Eustachian Tube Dysfunction","enrollment":80},{"nctId":"NCT06914908","phase":"PHASE2","title":"Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Study","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-05-12","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":64},{"nctId":"NCT06834347","phase":"PHASE3","title":"A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-02-12","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":210},{"nctId":"NCT06834360","phase":"PHASE3","title":"A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-02-06","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":210},{"nctId":"NCT07455916","phase":"NA","title":"Short-Term Effects of an AI-Based Wearable Adherence Monitor in Outpatient Psychiatry","status":"COMPLETED","sponsor":"Wonkwang University Hospital","startDate":"2022-12-31","conditions":"Mental Disease, Adherence to Care, Digital Health","enrollment":78},{"nctId":"NCT06726382","phase":"PHASE1","title":"KF2024#1-trial: Esketamine Interaction Study","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2024-12-09","conditions":"Drug Interactions, Food-drug Interaction","enrollment":12},{"nctId":"NCT06076304","phase":"PHASE4","title":"Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis","status":"RECRUITING","sponsor":"Daniel Merenstein","startDate":"2023-11-21","conditions":"Sinus Infection, Acute Sinusitis","enrollment":3720},{"nctId":"NCT04851301","phase":"PHASE1, PHASE2","title":"Neural Mechanisms of Immersive Virtual Reality in Chronic Pain","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2021-11-01","conditions":"Pain, Virtual Reality, Placebo","enrollment":259},{"nctId":"NCT06439381","phase":"PHASE2","title":"Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps","status":"RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2024-07-16","conditions":"Chronic Rhinosinusitis","enrollment":120},{"nctId":"NCT07416539","phase":"PHASE1","title":"Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID-19","status":"RECRUITING","sponsor":"Rokote Laboratories Finland Oy","startDate":"2026-02-10","conditions":"COVID - 19, SARS CoV-2","enrollment":20},{"nctId":"NCT06686446","phase":"NA","title":"Allergic Rhinitis Improvement Through Strategic Education: The ARISE Trial","status":"TERMINATED","sponsor":"Murdoch Childrens Research Institute","startDate":"2025-08-22","conditions":"Allergy","enrollment":18},{"nctId":"NCT06954428","phase":"PHASE1","title":"Clinical Trial of Intranasal Delivery of NT-301","status":"COMPLETED","sponsor":"Nano PharmaSolutions Australia","startDate":"2025-06-20","conditions":"Tolerability of NT-301 Nasal Spray, Pharmacokinetics of NT-301 Nasal Spray, Safety of NT-301 Nasal Spray","enrollment":49},{"nctId":"NCT04903002","phase":"PHASE2, PHASE3","title":"Evaluating the Efficacy of Intranasal Oxytocin on Chronic Pain","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial University of Newfoundland","startDate":"2022-04-01","conditions":"Chronic Pain","enrollment":336},{"nctId":"NCT07415278","phase":"PHASE4","title":"INTRANASAL FLUTICASONE VERSUS FLUTICASONE-AZELASTINE COMBINATION","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pamukkale University","startDate":"2022-12-01","conditions":"Allergic Rhinitis","enrollment":61},{"nctId":"NCT06295640","phase":"NA","title":"Relative Contribution of Brain Insulin Action for Postprandial Metabolism","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Ulm","startDate":"2024-03-18","conditions":"Glucose Metabolism Disorders","enrollment":31},{"nctId":"NCT06489548","phase":"PHASE2","title":"Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2025-09-16","conditions":"Dementia, Alzheimers Disease, Mild Cognitive Impairment Due to Alzheimer's Disease","enrollment":16},{"nctId":"NCT07222670","phase":"PHASE2","title":"A Study Assessing Safety, Tolerability, and Efficacy of INNA-051 in Preventing Respiratory Illness Due to Viral Infections in Healthy Adults 18 to 45 Years of Age","status":"RECRUITING","sponsor":"ENA Respiratory Pty Ltd","startDate":"2025-12-04","conditions":"Viral Respiratory Infection, Viral Respiratory Illnesses","enrollment":1100},{"nctId":"NCT07399717","phase":"NA","title":"Assessing Role of Probiotics in Children Aged 6-36 Months Treated for Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"Anabio R&D","startDate":"2026-01-26","conditions":"Pneumonia, Pneumonia in Children","enrollment":330},{"nctId":"NCT07398612","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Human Adipose-Derived Stem Cell Exosomes in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2026-01-31","conditions":"Acute Ischemic Stroke","enrollment":60},{"nctId":"NCT04404192","phase":"PHASE2","title":"PH94B in the Treatment of Adjustment Disorder With Anxiety","status":"COMPLETED","sponsor":"VistaGen Therapeutics, Inc.","startDate":"2021-10-12","conditions":"Adjustment Disorder With Anxious Mood","enrollment":41},{"nctId":"NCT06454240","phase":"PHASE2","title":"A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal Polyps","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2024-07-17","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":79},{"nctId":"NCT06809179","phase":"PHASE2","title":"A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder","status":"RECRUITING","sponsor":"VistaGen Therapeutics, Inc.","startDate":"2025-01-09","conditions":"Social Anxiety Disorder","enrollment":60},{"nctId":"NCT06615557","phase":"PHASE3","title":"Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)","status":"RECRUITING","sponsor":"VistaGen Therapeutics, Inc.","startDate":"2024-09-16","conditions":"Social Anxiety Disorder (SAD)","enrollment":236},{"nctId":"NCT07386873","phase":"NA","title":"The Efficacy of Olfactory Cleft Steroid Drops in Patients With CRS With Olfactory Cleft Obstruction","status":"NOT_YET_RECRUITING","sponsor":"Peking University Third Hospital","startDate":"2026-03-01","conditions":"Chronic Rhinosinusitis (CRS), Smell Dysfunction","enrollment":54},{"nctId":"NCT06705140","phase":"PHASE3","title":"A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers","status":"TERMINATED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2024-11-25","conditions":"RSV Immunisation","enrollment":947},{"nctId":"NCT06252285","phase":"PHASE3","title":"Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers","status":"TERMINATED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2024-02-06","conditions":"RSV Immunisation","enrollment":6300},{"nctId":"NCT06397768","phase":"PHASE3","title":"Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers","status":"TERMINATED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2024-05-13","conditions":"RSV Immunization","enrollment":2226},{"nctId":"NCT01471184","phase":"NA","title":"The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to Placebo","status":"COMPLETED","sponsor":"Bitop AG","startDate":"2009-09","conditions":"Allergic Rhinitis, Allergic Conjunctivitis","enrollment":46},{"nctId":"NCT01684540","phase":"","title":"Application of Ectoin® Rhinitis Nasal Spray in Patients With Acute Rhinosinusitis","status":"COMPLETED","sponsor":"Bitop AG","startDate":"2012-02","conditions":"Sinusitis","enrollment":66},{"nctId":"NCT02131038","phase":"","title":"Application of Ectoine Nasal Spray in Comparison With Cromolyn Sodium Containing Nasal Spray in Patients With Allergic Rhinitis","status":"COMPLETED","sponsor":"Bitop AG","startDate":"2009-05","conditions":"Allergic Rhinitis","enrollment":50},{"nctId":"NCT07304518","phase":"PHASE2","title":"Phase II Trial of PRT-064040 Nasal Spray for the Treatment of Migraine in Adults","status":"RECRUITING","sponsor":"Sichuan Purity Pharmaceutical Technology Co., Ltd.","startDate":"2026-01-26","conditions":"Migraine","enrollment":456},{"nctId":"NCT03881098","phase":"NA","title":"The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2019-12-06","conditions":"Lung Cancer","enrollment":240},{"nctId":"NCT04898764","phase":"PHASE4","title":"Research on Underlying Causes of Long-term Use of Nasal Decongestants and the Structured Withdrawal of the Decongestant","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2020-10-21","conditions":"Rhinitis Medicamentosa","enrollment":72},{"nctId":"NCT06755996","phase":"NA","title":"Dexmedetomidine Nasal Spray and Pediatric Bronchoscopy","status":"COMPLETED","sponsor":"Tongji Hospital","startDate":"2025-01-07","conditions":"Fiberoptic Bronchoscopy","enrollment":150},{"nctId":"NCT06943287","phase":"NA","title":"Pharmacist Intervention to Improve Smoking Cessation","status":"ENROLLING_BY_INVITATION","sponsor":"University of Iowa","startDate":"2025-08-11","conditions":"Smoking Cessation","enrollment":100},{"nctId":"NCT05687279","phase":"PHASE1, PHASE2","title":"Study on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among Close Contacts in Infants and Toddlers 6 to < 24 Months of Age in Puerto Rico (USA)","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2023-02-06","conditions":"Respiratory Syncytial Virus Infection","enrollment":80},{"nctId":"NCT02597647","phase":"PHASE1","title":"Bacterial Composition and Immune Responses in the Nose and Oropharynx During Influenza Infection","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2011-02","conditions":"Influenza","enrollment":17},{"nctId":"NCT07193901","phase":"PHASE2","title":"A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in Patients With Depression and Acute Suicidal Ideation or Behavior","status":"RECRUITING","sponsor":"Sichuan Purity Pharmaceutical Technology Co., Ltd.","startDate":"2025-05-27","conditions":"Major Depressive Disorder (MDD","enrollment":98},{"nctId":"NCT05603104","phase":"PHASE3","title":"Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure","status":"RECRUITING","sponsor":"Dr. Inge Winter","startDate":"2025-04-27","conditions":"Schizophrenia and Related Disorders, Major Depressive Disorder, Bipolar Depression","enrollment":1254},{"nctId":"NCT07350928","phase":"PHASE3","title":"Observation of the Effect of Preoperative Use of Dexmedetomidine Hydrochloride Nasal Spray on Optimizing Awake Sedation During Breast-Conserving Surgery for Breast Cancer and Postoperative Awake Status","status":"RECRUITING","sponsor":"Tianjin Medical University Cancer Institute and Hospital","startDate":"2025-03-01","conditions":"Breast Cancer","enrollment":394},{"nctId":"NCT06026514","phase":"PHASE1","title":"Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in Adults","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2023-09-18","conditions":"SARS-CoV-2 Infection","enrollment":27},{"nctId":"NCT04716153","phase":"NA","title":"Impact of a Sensory Rehabilitation Program on Olfactory-gustatory Alterations in Patients Treated With Chemotherapy for Haematological Cancer","status":"TERMINATED","sponsor":"University Hospital, Montpellier","startDate":"2021-06-25","conditions":"Multiple Myeloma, Olfactivo-gustatory Disorder, Lymphoma","enrollment":5},{"nctId":"NCT06083571","phase":"PHASE2","title":"Intranasal Ketorolac Trial","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2024-01-01","conditions":"Headache, Migraine","enrollment":41},{"nctId":"NCT07345442","phase":"PHASE1","title":"Study on the Safety, Tolerability, and Pharmacokinetics of PA9159 Nasal Spray in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Anhui Palo Alto Pharmaceuticals, Inc.","startDate":"2025-03-14","conditions":"Allergic Rhinitis","enrollment":36},{"nctId":"NCT07342556","phase":"NA","title":"Evaluating Modes of Influenza Transmission 2b Baseline SAR","status":"NOT_YET_RECRUITING","sponsor":"University of Maryland, College Park","startDate":"2026-01","conditions":"Influenza (Healthy Volunteers)","enrollment":80},{"nctId":"NCT06716021","phase":"PHASE3","title":"ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3","status":"NOT_YET_RECRUITING","sponsor":"Milestone Pharmaceuticals Inc.","startDate":"2027-01","conditions":"Atrial Fibrillation","enrollment":750},{"nctId":"NCT04218409","phase":"EARLY_PHASE1","title":"Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect Determination","status":"RECRUITING","sponsor":"University of Florida","startDate":"2021-09-02","conditions":"Pain","enrollment":45},{"nctId":"NCT06130449","phase":"EARLY_PHASE1","title":"Testosterone and Neural Function","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2024-04-01","conditions":"Spinal Cord Injury","enrollment":15},{"nctId":"NCT07324057","phase":"NA","title":"The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavioral Changes in Children With Autism Spectrum Disorder","status":"NOT_YET_RECRUITING","sponsor":"Sun Fei","startDate":"2026-02-01","conditions":"Autism Spectrum Disorder","enrollment":234},{"nctId":"NCT04490057","phase":"PHASE4","title":"A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV","status":"COMPLETED","sponsor":"Yale University","startDate":"2020-07-27","conditions":"Tobacco Use Cessation","enrollment":323},{"nctId":"NCT06036004","phase":"PHASE2","title":"Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-01-08","conditions":"Central Diabetes Insipidus (cDI)","enrollment":112},{"nctId":"NCT07308015","phase":"PHASE4","title":"Clinical Study on the Treatment of Rhinitis Sicca With Sodium Hyaluronate Adjustable Nasal Irrigator","status":"RECRUITING","sponsor":"China-Japan Union Hospital","startDate":"2025-06-16","conditions":"Rhinitis Sicca","enrollment":200},{"nctId":"NCT07299630","phase":"PHASE3","title":"Blocking Sphenopalatine Ganglion by Intranasal Lidocaine Spray in Partial Turbinectomy Surgeries","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-12-20","conditions":"Turbinate Surgery, Sphenopalatine Block","enrollment":50},{"nctId":"NCT07298525","phase":"PHASE4","title":"Safety Exploration and Evaluation of Dexmedetomidine Hydrochloride Nasal Spray for Pre-anesthesia Sedation in Low-Monitoring Settings","status":"NOT_YET_RECRUITING","sponsor":"Sichuan Provincial People's Hospital","startDate":"2026-01-10","conditions":"Dexmedetomidine, Sedation, Safety","enrollment":564},{"nctId":"NCT04962477","phase":"","title":"Understanding Host-pathogen Interaction in the Respiratory Mucosa During Pregnancy","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2022-03-02","conditions":"Pregnancy Related, Innate Inflammatory Response","enrollment":48},{"nctId":"NCT07093281","phase":"PHASE4","title":"Intranasal LAIV Mucosal Immunity Examination","status":"NOT_YET_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2026-02","conditions":"Impact of Vaccination","enrollment":25},{"nctId":"NCT07294326","phase":"PHASE4","title":"A Prospective, Randomized, Controlled Study Comparing the Efficacy of Intranasal Corticosteroids (INCS) Combined With Intranasal Antihistamines (INAH) and INCS Combined With Oral Antihistamines (OAH) in the Treatment of Moderate to Severe Allergic Rhinitis Symptoms","status":"NOT_YET_RECRUITING","sponsor":"China-Japan Union Hospital","startDate":"2026-01-01","conditions":"Allergic Rhinitis","enrollment":50},{"nctId":"NCT06821126","phase":"PHASE1, PHASE2","title":"Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults","status":"RECRUITING","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2025-05-09","conditions":"Healthy","enrollment":238},{"nctId":"NCT06552130","phase":"NA","title":"The Importance of Insulin Action in the Brain for the Immune System During Physical Activity","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Ulm","startDate":"2024-12-15","conditions":"Insulin Sensitivity","enrollment":20},{"nctId":"NCT04650841","phase":"EARLY_PHASE1","title":"The Role of the Opioid System in Placebo Effects on Pain and Social Rejection","status":"NOT_YET_RECRUITING","sponsor":"Trustees of Dartmouth College","startDate":"2026-09-01","conditions":"Pain, Rejection, Placebo Effect","enrollment":60},{"nctId":"NCT07240922","phase":"PHASE4","title":"The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE III) Study","status":"RECRUITING","sponsor":"The University of Hong Kong","startDate":"2025-10-01","conditions":"Influenza","enrollment":600},{"nctId":"NCT07270302","phase":"PHASE1, PHASE2","title":"Nebulized Nasal Steroids","status":"NOT_YET_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2025-12","conditions":"Chronic Rhinosinusitis","enrollment":50},{"nctId":"NCT06851611","phase":"PHASE1","title":"The Safety and Antibody Response of the Nasal COV2 Vaccine Against the SARS-CoV-2 Virus","status":"COMPLETED","sponsor":"Rokote Laboratories Finland Oy","startDate":"2025-01-21","conditions":"COVID19, Sars-Cov-2","enrollment":40},{"nctId":"NCT07266688","phase":"NA","title":"Evaluation of Bactorinol® Nasal Spray in Adult Patients With Vasomotor Rhinitis","status":"NOT_YET_RECRUITING","sponsor":"Liaquat University of Medical & Health Sciences","startDate":"2025-12-01","conditions":"Vasomotor Rhinitis","enrollment":100},{"nctId":"NCT07265180","phase":"NA","title":"Oxytocin-Augmented Group Psychotherapy for Patients With Schizophrenia - an Oxytocin-dose Comparison","status":"RECRUITING","sponsor":"Charite University, Berlin, Germany","startDate":"2025-09-08","conditions":"Schizophrenia Spectrum Disorders (SSD)","enrollment":120},{"nctId":"NCT07016516","phase":"PHASE1","title":"A Study to Learn About PRT-064040 Nasal Spray in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Sichuan Purity Pharmaceutical Technology Co., Ltd.","startDate":"2025-06-07","conditions":"Migraine","enrollment":80},{"nctId":"NCT04620369","phase":"PHASE3","title":"Rose Geranium in Sesame Oil Nasal Spray for the Improvement of Nasal Vestibulitis Symptoms in Cancer Patients Receiving Chemotherapy","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2020-11-13","conditions":"Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Nasal Vestibulitis","enrollment":106},{"nctId":"NCT06420297","phase":"PHASE3","title":"OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome","status":"ENROLLING_BY_INVITATION","sponsor":"ACADIA Pharmaceuticals Inc.","startDate":"2024-03-11","conditions":"Hyperphagia in Prader-Willi Syndrome","enrollment":160},{"nctId":"NCT07262450","phase":"NA","title":"Assessement of Effectiveness of Seawater Nasal Sprays on Sinonasal Symptoms","status":"RECRUITING","sponsor":"Laboratoire de la Mer","startDate":"2025-08-27","conditions":"URTI, Bronchiolitis, COVID - 19","enrollment":1065},{"nctId":"NCT05076682","phase":"PHASE2","title":"Reverse Triple Negative Immune Resistant Breast Cancer","status":"RECRUITING","sponsor":"Fudan University","startDate":"2022-06-30","conditions":"Triple-negative Breast Cancer","enrollment":80},{"nctId":"NCT07259538","phase":"PHASE1","title":"A Phase I Study Evaluating the Safety, Tolerability, and Pharmacokinetics of VVN432 Nasal Spray","status":"RECRUITING","sponsor":"VivaVision Biotech, Inc","startDate":"2025-11-06","conditions":"Chronic Rhinosinusitis (CRS)","enrollment":60},{"nctId":"NCT07257224","phase":"","title":"Post-market Clinical Follow-up Study of an Isotonic Saline Solution to Manage Nasal Congestion in Case of Flu Symptoms, Colds, Allergic Rhinitis and Rhinosinusitis in Infants and Toddlers","status":"NOT_YET_RECRUITING","sponsor":"Laboratoires Quinton International S.L.","startDate":"2025-12","conditions":"Nasal Congestion, Common Cold, Allergic Rhinitis","enrollment":83},{"nctId":"NCT06136390","phase":"NA","title":"OXYMIND: Oxytocin-augmented Group Psychotherapy for Patients With Schizophrenia","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2023-09-30","conditions":"Schizophrenia Spectrum Disorders","enrollment":42},{"nctId":"NCT07230197","phase":"NA","title":"The Efficacy and Safety of Pregabalin Combined With Dexmedetomidine in Patients With Fibromyalgia","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-09-30","conditions":"Fibromyalgia, Pregabalin, Dexmedetomidine","enrollment":400},{"nctId":"NCT07204106","phase":"NA","title":"Efficacy Study of Dexmedetomidine Nasal Spray Combined With Propofol for Deep Sedation in ERCP","status":"COMPLETED","sponsor":"Shiyou Wei","startDate":"2025-10-02","conditions":"Dexmedetomidine Induced Sedation, Nasal Administration, Sprays","enrollment":180},{"nctId":"NCT06358651","phase":"PHASE3","title":"Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)","status":"ACTIVE_NOT_RECRUITING","sponsor":"VistaGen Therapeutics, Inc.","startDate":"2024-03-28","conditions":"Social Anxiety Disorder","enrollment":238},{"nctId":"NCT05011396","phase":"PHASE3","title":"PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2","status":"TERMINATED","sponsor":"VistaGen Therapeutics, Inc.","startDate":"2021-08-30","conditions":"Social Anxiety Disorder","enrollment":228},{"nctId":"NCT07243561","phase":"PHASE1, PHASE2","title":"Prospective Clinical Study on Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Childhood Autism","status":"RECRUITING","sponsor":"Dongfang People's Hospital","startDate":"2025-11-30","conditions":"Autism Spectrum Disorder (ASD, Prospective Study","enrollment":40},{"nctId":"NCT06580210","phase":"","title":"Performance and Safety Assessment of the Mechanical Decongestant Seawater Spray Enriched With Essential Oils From Laboratoires Gilbert in Patient With Acute Rhinitis Associated With Nasal Obstruction","status":"RECRUITING","sponsor":"Laboratoires Gilbert","startDate":"2024-10-22","conditions":"Acute Rhinitis, Nasal Obstruction, Rhinosinusitis","enrollment":114},{"nctId":"NCT06451640","phase":"PHASE2","title":"A Extension Clinical Study of TQC2731 Injection in the Treatment of Chronic Sinusitis With Nasal Polyps","status":"COMPLETED","sponsor":"Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.","startDate":"2024-07-04","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":59},{"nctId":"NCT07240376","phase":"NA","title":"Efficacy and Safety of Stapokibart in Non-Allergic Rhinitis With Eosinophilia Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Huazhong University of Science and Technology","startDate":"2025-11-25","conditions":"Non-Allergic Rhinitis With Eosinophilia Syndrome","enrollment":90},{"nctId":"NCT07000877","phase":"PHASE4","title":"Nasal Decongestant to Reduce Perioperative Adverse Events in Children With Upper Respiratory Track Infections Having Anesthesia.","status":"RECRUITING","sponsor":"Telethon Kids Institute","startDate":"2025-06-25","conditions":"Perioperative Respiratory Adverse Events, Anesthesia Outcomes","enrollment":200},{"nctId":"NCT05299086","phase":"PHASE3","title":"As Needed Versus Regular Intranasal Corticosteroid in Children With Perennial Allergic Rhinitis","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2022-04-04","conditions":"Perennial Allergic Rhinitis, Child, Only","enrollment":68},{"nctId":"NCT05664516","phase":"PHASE2","title":"A Study of the Effects of Oxytocin in Adults With Binge-eating Disorder","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2023-03-07","conditions":"Binge-eating Disorder","enrollment":60},{"nctId":"NCT07228325","phase":"PHASE1, PHASE2","title":"Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic Rhinitis","status":"ENROLLING_BY_INVITATION","sponsor":"Nasus Pharma","startDate":"2025-11-03","conditions":"Anaphylaxis, Allergy","enrollment":50},{"nctId":"NCT06691113","phase":"PHASE2","title":"A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2024-12-16","conditions":"Chronic Rhinosinusitis Without Nasal Polyps","enrollment":60},{"nctId":"NCT06364228","phase":"PHASE2","title":"Intranasal Oxytocin Intervention for Caregivers to Persons With Dementia","status":"RECRUITING","sponsor":"University of Nebraska","startDate":"2026-01-05","conditions":"Stress","enrollment":32}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":687,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Nasal Sprays","genericName":"Nasal Sprays","companyName":"University of Electronic Science and Technology of China","companyId":"university-of-electronic-science-and-technology-of-china","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":false,"safety":true,"trials":true,"score":3}}